These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 23831947)
1. [Glial and glioneuronal tumors in adults and children: main genetic alterations and towards a histomolecular classification]. Figarella-Branger D; Chappe C; Padovani L; Mercurio S; Colin C; Forest F; Bouvier C Bull Cancer; 2013; 100(7-8):715-26. PubMed ID: 23831947 [TBL] [Abstract][Full Text] [Related]
2. Histomolecular classification of adult diffuse gliomas: the diagnostic value of immunohistochemical markers. Figarella-Branger D; Maues de Paula A; Colin C; Bouvier C Rev Neurol (Paris); 2011 Oct; 167(10):683-90. PubMed ID: 21889777 [TBL] [Abstract][Full Text] [Related]
3. [Histological and molecular classification of gliomas]. Figarella-Branger D; Colin C; Coulibaly B; Quilichini B; Maues De Paula A; Fernandez C; Bouvier C Rev Neurol (Paris); 2008; 164(6-7):505-15. PubMed ID: 18565348 [TBL] [Abstract][Full Text] [Related]
4. Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma. Schindler G; Capper D; Meyer J; Janzarik W; Omran H; Herold-Mende C; Schmieder K; Wesseling P; Mawrin C; Hasselblatt M; Louis DN; Korshunov A; Pfister S; Hartmann C; Paulus W; Reifenberger G; von Deimling A Acta Neuropathol; 2011 Mar; 121(3):397-405. PubMed ID: 21274720 [TBL] [Abstract][Full Text] [Related]
5. Molecular pathways in gliomagenesis and their relevance to neuropathologic diagnosis. Appin CL; Brat DJ Adv Anat Pathol; 2015 Jan; 22(1):50-8. PubMed ID: 25461780 [TBL] [Abstract][Full Text] [Related]
6. Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology. Qaddoumi I; Orisme W; Wen J; Santiago T; Gupta K; Dalton JD; Tang B; Haupfear K; Punchihewa C; Easton J; Mulder H; Boggs K; Shao Y; Rusch M; Becksfort J; Gupta P; Wang S; Lee RP; Brat D; Peter Collins V; Dahiya S; George D; Konomos W; Kurian KM; McFadden K; Serafini LN; Nickols H; Perry A; Shurtleff S; Gajjar A; Boop FA; Klimo PD; Mardis ER; Wilson RK; Baker SJ; Zhang J; Wu G; Downing JR; Tatevossian RG; Ellison DW Acta Neuropathol; 2016 Jun; 131(6):833-45. PubMed ID: 26810070 [TBL] [Abstract][Full Text] [Related]
7. BRAF alterations in primary glial and glioneuronal neoplasms of the central nervous system with identification of 2 novel KIAA1549:BRAF fusion variants. Lin A; Rodriguez FJ; Karajannis MA; Williams SC; Legault G; Zagzag D; Burger PC; Allen JC; Eberhart CG; Bar EE J Neuropathol Exp Neurol; 2012 Jan; 71(1):66-72. PubMed ID: 22157620 [TBL] [Abstract][Full Text] [Related]
8. Molecular genetics of gliomas. Appin CL; Brat DJ Cancer J; 2014; 20(1):66-72. PubMed ID: 24445767 [TBL] [Abstract][Full Text] [Related]
9. Glioma biology and molecular markers. Cohen AL; Colman H Cancer Treat Res; 2015; 163():15-30. PubMed ID: 25468223 [TBL] [Abstract][Full Text] [Related]
10. [Histological classification of human gliomas: state of art and controversies]. Figarella-Branger D; Bouvier C Bull Cancer; 2005 Apr; 92(4):301-9. PubMed ID: 15888386 [TBL] [Abstract][Full Text] [Related]
11. Analysis of IDH1-R132 mutation, BRAF V600 mutation and KIAA1549-BRAF fusion transcript status in central nervous system tumors supports pediatric tumor classification. Gierke M; Sperveslage J; Schwab D; Beschorner R; Ebinger M; Schuhmann MU; Schittenhelm J J Cancer Res Clin Oncol; 2016 Jan; 142(1):89-100. PubMed ID: 26115961 [TBL] [Abstract][Full Text] [Related]
12. Pathologic and molecular aspects of anaplasia in circumscribed gliomas and glioneuronal tumors. Pujadas E; Chen L; Rodriguez FJ Brain Tumor Pathol; 2019 Apr; 36(2):40-51. PubMed ID: 30859342 [TBL] [Abstract][Full Text] [Related]
13. New IDH1 I113T mutation associated with BRAF V600E mutation: new driver of gliomagenesis? Tabouret E; Fina F; Vincentelli F; Nanni I; Figarella-Branger D J Neurol Sci; 2014 Jul; 342(1-2):204-6. PubMed ID: 24857351 [TBL] [Abstract][Full Text] [Related]
14. Histologic classification of gliomas. Perry A; Wesseling P Handb Clin Neurol; 2016; 134():71-95. PubMed ID: 26948349 [TBL] [Abstract][Full Text] [Related]
15. [Genetics and brain gliomas]. Alentorn A; Labussière M; Sanson M; Delattre JY; Hoang-Xuan K; Idbaih A Presse Med; 2013 May; 42(5):806-13. PubMed ID: 22789312 [TBL] [Abstract][Full Text] [Related]
16. BRAF V600E-mutated diffuse glioma in an adult patient: a case report and review. Suzuki Y; Takahashi-Fujigasaki J; Akasaki Y; Matsushima S; Mori R; Karagiozov K; Joki T; Ikeuchi S; Ikegami M; Manome Y; Murayama Y Brain Tumor Pathol; 2016 Jan; 33(1):40-9. PubMed ID: 26445861 [TBL] [Abstract][Full Text] [Related]
17. WHO 2016 Classification of gliomas. Wesseling P; Capper D Neuropathol Appl Neurobiol; 2018 Feb; 44(2):139-150. PubMed ID: 28815663 [TBL] [Abstract][Full Text] [Related]
18. Multidimensional scaling of diffuse gliomas: application to the 2016 World Health Organization classification system with prognostically relevant molecular subtype discovery. Cimino PJ; Zager M; McFerrin L; Wirsching HG; Bolouri H; Hentschel B; von Deimling A; Jones D; Reifenberger G; Weller M; Holland EC Acta Neuropathol Commun; 2017 May; 5(1):39. PubMed ID: 28532485 [TBL] [Abstract][Full Text] [Related]
19. Molecular classification of adult gliomas: recent advances and future perspectives. Barritault M; Meyronet D; Ducray F Curr Opin Oncol; 2018 Nov; 30(6):375-382. PubMed ID: 30148717 [TBL] [Abstract][Full Text] [Related]